9 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Female cancer prediction using cervical omics to individualise screening and prevention (FORECEE)
Date du début: 1 sept. 2015, Date de fin: 31 août 2019,
While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (human papilloma virus); together these enable identification of high risk individuals and interventions t ...
Voir le projet
14
Participants partenaires
TERMINÉ
Biomarker Development for Postoperative Cognitive Impairment in the Elderly (BioCog)
Date du début: 1 févr. 2014, Date de fin: 31 janv. 2019,
Postoperative delirium (POD) is characterized by the progressive deterioration of sensory/cognitive function after surgery with incidences of up to 30-80%. It is frequently followed by postoperative cognitive dysfunction (POCD) which tends to persist over time. In elderly patients, POCD resembles chronic dementia and appears to accelerate the cognitive decline in Alzheimer dementia. POD is strongl ...
Voir le projet
12
Participants partenaires
TERMINÉ
Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis (ADIPOA2)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2018,
Osteoarthritis (OA) is an incurable disease that has evaded pharmacological interference, biologic therapy or surgical intervention to prevent disease progression. Currently, OA is designated the 11th highest contributor (of 291 diseases) of global disability. In the absence of effective treatment options, cellular therapies using mesenchymal stem/stromal cells (MSCs) have emerged as potential can ...
Voir le projet
20
Participants partenaires
TERMINÉ
Development of Coordination Mechanisms During Different Kinds of Emergencies (COncORDE)
Date du début: 1 mai 2014, Date de fin: 30 avr. 2017,
The threat of mass casualty incidents or medical surges to healthcare systems has always been present. Preparing essential parts of the healthcare system such as hospitals and their partners to prevent, respond, and rapidly recover from these threats is critical for protecting and securing the entire health infrastructure. Large-scale disaster situations causing mass casualty incidents are charact ...
Voir le projet
17
Participants partenaires
TERMINÉ
European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity (EuroTARGET)
Date du début: 1 mars 2011, Date de fin: 31 août 2016,
Each year more than 63,000 new cases of kidney cancer are diagnosed in the European Union. Approx. 50% of all patients have metastasized renal cell cancer (mRCC) at presentation or develop metastases during follow-up. 5-year relative survival of mRCC has been extremely poor: between 5 and 10%. In the past few years, so-called targeted therapies that suppress angiogenesis have changed the clinical ...
Voir le projet
15
Participants partenaires
TERMINÉ
Open Semantically-enabled, Social-aware Access to Scientific Data (OpenScienceLink)
Date du début: 1 févr. 2013, Date de fin: 31 janv. 2016,
OpenScienceLink will introduce and pilot a holistic approach to the publication, sharing, linking, review and evaluation of research results, based on the open access to scientific information. OpenScienceLink will pilot a range of novel services that could alleviate the lack of structured data journals and associated data models, the weaknesses of the review process, the poor linking of scientifi ...
Voir le projet
9
Participants partenaires
TERMINÉ
Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention (DALI)
Date du début: 1 mars 2010, Date de fin: 31 déc. 2015,
Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a more sedentary lifestyle. Evidence is accumulating that gestational diabetes mellitus (GDM) may be playing a role in this process. Thus it provides a significant opportunity for preventing future T2D. Not only is GDM prevalence on the rise, but intrauterine ex ...
Voir le projet
18
Participants partenaires
TERMINÉ
Advanced Materials & Pharmaceutical TEChnologies (AMPTEC)
Date du début: 31 déc. 2013, Date de fin: 29 sept. 2014,
The Advanced Materials and Pharmaceutical Technologies cluster will gather some of the world leading researchers who want to undertake an innovative project by joining forces and pooling their respective skills.With their expertise on materials sciences, pharmaceutics, continuous processing technologies and medical devices, they will meet new challenges in pharmaceutical and medical development. C ...
Voir le projet
12
Participants partenaires
TERMINÉ
Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs to other Indications (PONTE)
Date du début: 1 mars 2010, Date de fin: 28 févr. 2013,
Description
PONTE is a European project standing for Efficient Patient Recruitment for Innovative Clinical Trials of Existing Drugs to other Indications.PONTE provides a platform following a Service Oriented Architecture (SOA) approach that offers intelligent automatic identification of individuals eligible to participate in clinical trials ...
Voir le projet